Bio Path Holdings Stock Price Prediction
BPTH Stock | USD 3.00 0.29 10.70% |
Oversold Vs Overbought
33
Oversold | Overbought |
Bio Path Holdings stock price prediction is an act of determining the future value of Bio Path shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Bio Path's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Bio Path and does not consider all of the tangible or intangible factors available from Bio Path's fundamental data. We analyze noise-free headlines and recent hype associated with Bio Path Holdings, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Bio Path's stock price prediction:EPS Estimate Next Quarter (4.80) | EPS Estimate Current Year (18.71) | EPS Estimate Next Year (18.41) | Wall Street Target Price 40 | EPS Estimate Current Quarter (5.40) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Bio Path based on different types of headlines from major news networks to social media. The Bio stock price prediction module provides an analysis of price elasticity to changes in media outlook on Bio Path over a specific investment horizon. Using Bio Path hype-based prediction, you can estimate the value of Bio Path Holdings from the perspective of Bio Path response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Bio Path using Bio Path's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Bio using crowd psychology based on the activity and movement of Bio Path's stock price.
Bio Path Implied Volatility | 0.0 |
Bio Path's implied volatility exposes the market's sentiment of Bio Path Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bio Path's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bio Path stock will not fluctuate a lot when Bio Path's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Bio Path. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Bio Path to buy its stock at a price that has no basis in reality. In that case, they are not buying Bio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bio Path after-hype prediction price | USD 2.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bio |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Path After-Hype Price Prediction Density Analysis
As far as predicting the price of Bio Path at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio Path or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bio Path, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Bio Path Estimiated After-Hype Price Volatility
In the context of predicting Bio Path's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio Path's historical news coverage. Bio Path's after-hype downside and upside margins for the prediction period are 0.14 and 11.16, respectively. We have considered Bio Path's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bio Path is dangerous at this time. Analysis and calculation of next after-hype price of Bio Path Holdings is based on 3 months time horizon.
Bio Path Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bio Path is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Path backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio Path, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.37 | 8.66 | 0.23 | 0.22 | 8 Events / Month | 8 Events / Month | In about 8 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.00 | 2.71 | 0.00 |
|
Bio Path Hype Timeline
Bio Path Holdings is currently traded for 3.00. The entity has historical hype elasticity of -0.23, and average elasticity to hype of competition of 0.22. Bio is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -1.37%. %. The volatility of related hype on Bio Path is about 5504.24%, with the expected price after the next announcement by competition of 3.22. The company recorded a loss per share of 33.63. Bio Path Holdings last dividend was issued on the 18th of January 2019. The entity had 1:20 split on the 23rd of February 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Bio Path Basic Forecasting Models to cross-verify your projections.Bio Path Related Hype Analysis
Having access to credible news sources related to Bio Path's direct competition is more important than ever and may enhance your ability to predict Bio Path's future price movements. Getting to know how Bio Path's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio Path may potentially react to the hype associated with one of its peers.
Bio Path Additional Predictive Modules
Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Bio Path Predictive Indicators
The successful prediction of Bio Path stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bio Path Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bio Path based on analysis of Bio Path hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bio Path's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bio Path's related companies. 2021 | 2022 | 2023 (projected) | Payables Turnover | 1.52 | 0.27 | 0.39 | Days Of Inventory On Hand | 1.19 | 7.36 | 1.3 |
Story Coverage note for Bio Path
The number of cover stories for Bio Path depends on current market conditions and Bio Path's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bio Path is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bio Path's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Bio Path Short Properties
Bio Path's future price predictability will typically decrease when Bio Path's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bio Path Holdings often depends not only on the future outlook of the potential Bio Path's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Path's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 478 K | |
Cash And Short Term Investments | 1.1 M |
Check out Bio Path Basic Forecasting Models to cross-verify your projections. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Bio Stock analysis
When running Bio Path's price analysis, check to measure Bio Path's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Path is operating at the current time. Most of Bio Path's value examination focuses on studying past and present price action to predict the probability of Bio Path's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Path's price. Additionally, you may evaluate how the addition of Bio Path to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Bio Path's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Path. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Path listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (33.63) | Return On Assets (1.03) | Return On Equity (2.20) |
The market value of Bio Path Holdings is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Path's value that differs from its market value or its book value, called intrinsic value, which is Bio Path's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Path's market value can be influenced by many factors that don't directly affect Bio Path's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Path's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Path is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Path's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.